Helen Louise Collins - CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Helen Louise Collins - trading volume in the past year for Enliven Therapeutics, Inc.

Holdings reported by Helen Louise Collins for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $25.07 Apr 11, 2024 Direct
Stock Option (right to buy) 267K Apr 11, 2024 Direct Common Stock

Transactions reported by Helen Louise Collins for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership